3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Promyelocytic, Acute
27
Leukemia, Myeloid, Acute
27
Leukemia
16
Myelodysplastic Syndromes
13
Multiple Myeloma
9
Neuroblastoma
5
Melanoma
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Hematologic Neoplasms
4
Congenital Abnormalities
4
Uterine Cervical Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Anemia, Refractory, with Excess of Blasts
3
Thrombocytopenia
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Interventions
Cisplatin
29
Magnetic Resonance Spectroscopy
16
Specimen Handling
13
pembrolizumab
11
Radiotherapy, Intensity-Modulated
11
Radiotherapy
11
Cetuximab
11
Paclitaxel
9
Fluorouracil
9
Docetaxel
9
Surgical Procedures, Operative
8
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiation
6
Carboplatin
6
Taxes
5
toripalimab
4
X-Rays
4
Fluorodeoxyglucose F18
4
Celecoxib
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Chemoradiotherapy
3
130-nm albumin-bound paclitaxel
3
motexafin gadolinium
2
ipatasertib
2
camrelizumab
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hypopharyngeal Neoplasms
×
Tretinoin
×
Clear all
NCT06706401
2026-04-24
LYSARI
Centre Leon Berard
Phase 3
Recruiting
460 enrolled